Due to unclear histological origin, it has been classified as a hybrid ovarian tumor by World Health Organization in 2020.[7] Witkowski et al[8] found that SMARCA4 mutation played a key role in the development and progression of SCCOHT. This evidence concerns the gene SMARCA4 and ovarian neoplasm.